Synonyms: Busulfex IV® | Myleran®
busulfan is an approved drug (FDA (1954), EMA (2003))
Compound class:
Synthetic organic
Comment: Busulfan is a DNA alkylating agent. It has an immunosuppressive effect on bone marrow, especially inhibiting growth of granulocytes.
![]() View more information in the IUPHAR Pharmacology Education Project: busulfan |
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. FDA (1954) | EMA (2003) |
IUPAC Name ![]() |
4-(methanesulfonyloxy)butyl methanesulfonate |
International Nonproprietary Names ![]() |
|
INN number | INN |
564 | busulfan |
Synonyms ![]() |
Busulfex IV® | Myleran® |
Database Links ![]() |
|
CAS Registry No. | 55-98-1 |
ChEMBL Ligand | CHEMBL820 |
DrugBank Ligand | DB01008 |
DrugCentral Ligand | 438 |
GtoPdb PubChem SID | 178103712 |
PubChem CID | 2478 |
Search Google for chemical match using the InChIKey | COVZYZSDYWQREU-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | COVZYZSDYWQREU |
Search PubMed clinical trials | busulfan |
Search PubMed titles | busulfan |
Search PubMed titles/abstracts | busulfan |
UniChem Compound Search for chemical match using the InChIKey | COVZYZSDYWQREU-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | COVZYZSDYWQREU-UHFFFAOYSA-N |
Wikipedia | Busulfan |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Busulfan (links to external site)
Cat. No. HY-B0245 |